Programmable spatiotemporal control of CRISPR-Cas12a: Engineering precision for next-generation gene editing and diagnostics

CRISPR-Cas12a has emerged as a versatile alternative to Cas9, offering distinct advantages, such as recognition of thymine-rich protospacer adjacent motifs, generation of staggered 5' DNA breaks, simplified guide RNA architecture, and collateral (trans) single-stranded DNA cleavage. These features have enabled applications ranging from gene regulation to ultrasensitive nucleic-acid detection. However, Cas12a is typically activated immediately upon target engagement and may lack intrinsic mechanisms for restricting activity in time or space, which can increase off-target effects, systemic exposure, and loss of tissue specificity in certain contexts. Consequently, strategies that enable precise spatiotemporal control of Cas12a activity are increasingly important. Recent advances, including photocaged repeat-recognition sequence-based designs, split-crRNA architectures, chemically inducible systems, and kinetic optimization approaches, provide effective means to modulate Cas12a activation with improved precision. In diagnostic settings, temporal gating enhances signal fidelity by reducing background and false-positive readouts, while in therapeutic applications, controlled activation may enable tissue-restricted editing and safer, reversible gene regulation. This review summarizes current strategies for programmable spatiotemporal control of Cas12a, integrating mechanistic insights with emerging translational considerations, and outlines remaining challenges and opportunities for advancing safe and precise genome engineering.